{"transactions":[{"id":977261,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":72048,"kind":"person","name":"Thomas Brian C.","position":1,"cik":"0001996097","reported_name":"Thomas Brian C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-08T18:56:16.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":3830,"price":1.7719,"value":6786.377,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person."}],"balance_after":2510960,"source":{"system":"sec-edgar","filing":"0001193125-25-310971","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312525310971/ownership.xml","form_type":"4"}},{"id":984783,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":72048,"kind":"person","name":"Thomas Brian C.","position":1,"cik":"0001996097","reported_name":"Thomas Brian C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-02T00:34:10.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":2701,"price":1.81,"value":4888.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the Reporting Person."}],"balance_after":2514790,"source":{"system":"sec-edgar","filing":"0001193125-25-304221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312525304221/ownership.xml","form_type":"4"}},{"id":1117238,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":72048,"kind":"person","name":"Thomas Brian C.","position":1,"cik":"0001996097","reported_name":"Thomas Brian C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-09T22:50:36.000Z","date":"2025-06-06","kind":"sale","planned":false,"acquired":false,"shares":10785,"price":1.75,"value":18873.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person."}],"balance_after":2517491,"source":{"system":"sec-edgar","filing":"0000950170-25-083947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017025083947/ownership.xml","form_type":"4"}},{"id":1178605,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":72048,"kind":"person","name":"Thomas Brian C.","position":1,"cik":"0001996097","reported_name":"Thomas Brian C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T15:58:17.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":196000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":196000,"derivative":{"exercise_price":1.32,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":196000},"source":{"system":"sec-edgar","filing":"0000950170-25-050102","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017025050102/ownership.xml","form_type":"4"}},{"id":1178604,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":72048,"kind":"person","name":"Thomas Brian C.","position":1,"cik":"0001996097","reported_name":"Thomas Brian C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-03T15:58:17.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). 25% of the RSUs shall vest on June 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":2528276,"source":{"system":"sec-edgar","filing":"0000950170-25-050102","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017025050102/ownership.xml","form_type":"4"}},{"id":1548406,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":72048,"kind":"person","name":"Thomas Brian C.","position":1,"cik":"0001996097","reported_name":"Thomas Brian C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-04T00:00:22.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":500323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on April 1, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":500323,"derivative":{"exercise_price":10.82,"expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":500323},"source":{"system":"sec-edgar","filing":"0000950170-24-041449","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017024041449/ownership.xml","form_type":"4"}},{"id":1548405,"issuer":{"id":7270,"kind":"organization","name":"Metagenomi Therapeutics, Inc.","symbol":"MGX"},"owners":[{"id":72048,"kind":"person","name":"Thomas Brian C.","position":1,"cik":"0001996097","reported_name":"Thomas Brian C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-04T00:00:22.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":118992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). 25% of the RSUs shall vest on June 5, 2025, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":2496276,"source":{"system":"sec-edgar","filing":"0000950170-24-041449","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785279/000095017024041449/ownership.xml","form_type":"4"}}]}